Viking DNA helps reveal when HIV-fighting gene mutation emerged: 9,000 years ago near the Black Sea
When you buy through links on our articles, Future and its syndication partners may earn a commission.
A gene variant that helps protect people from HIV infection likely originated in people who lived during the span of time between the Stone Age and the Viking Age, a new study of thousands of genomes reveals.
"It turns out that the variant arose in one individual who lived in an area near the Black Sea between 6,700 and 9,000 years ago," Simon Rasmussen, a bioinformatics expert at the University of Copenhagen and co-senior author of the study, said in a statement. The variant must have been helpful for something else in the past, since HIV in humans is less than a century old.
In a study published May 5 in the journal Cell, Rasmussen and his colleagues detailed their search for the origin of a genetic mutation known as CCR5 delta 32. CCR5 is a protein predominantly found in immune cells that many — but not all — HIV strains use to break into those cells and trigger infection.
But in people with two copies of the CCR5 delta 32 mutation, the protein gets disabled, essentially "locking out" the HIV virus. Scientists have taken advantage of this mutation to cure a handful of people of HIV.
Related: Mysterious case of the 'Geneva patient,' the latest person in long-term remission from HIV, raises questions
Scientists have learned that this variant makes up 10% to 16% of CCR5 genes seen in European populations. However, attempts to identify its origin and trace its spread have previously come up short, since ancient genomes are often extremely fragmentary.
In the new study, the research team identified the mutation in 2,504 genomes from modern humans sampled for the 1000 Genomes Project, an international effort to catalog human genetic variation. Then, they created a model to search 934 ancient genomes from various regions of Eurasia ranging from the early Mesolithic period to the Viking Age, from roughly 8000 B.C. to A.D. 1000.
"By looking at this large dataset, we can determine where and when the mutation arose," study co-author Kirstine Ravn, a researcher at the University of Copenhagen, said in the statement.
The team's genetic detective work revealed that the person who first carried this mutation lived near the Black Sea around 7000 B.C., around the time early farmers arrived in Europe via Western Asia. The researchers also discovered that the prevalence of the mutation exploded between 8,000 and 2,000 years ago, suggesting it was extremely useful as people moved out of the Eurasian steppe.
The study's findings contradict previous assumptions that the mutation emerged more recently. For instance, this means that the increase in the frequency of the mutation did not result from medieval plagues or from Viking exploration, which may have introduced pressure for humans' immune cells to evolve.
When it's not being ransacked by HIV, the CCR5 protein helps control how immune cells respond to signals called chemokines, likely helping direct cells to sites of inflammation in the body.
RELATED STORIES
—1,500 ancient European genomes reveal previously hidden waves of migration, study finds
—Ancient hunter-gatherer DNA linked to higher BMI in modern Japanese people
—Ancient DNA and modern genomes can reveal stories of past peoples, from the Iron Age to Chernobyl, geneticist says
The researchers suggest that people who carried the special CCR5 variant had an advantage. "People with this mutation were better at surviving, likely because it dampened the immune system during a time when humans were exposed to new pathogens," study co-author Leonardo Cobuccio, a postdoctoral researcher at the University of Copenhagen, said in the statement. While this sounds negative, an overly aggressive immune system can be deadly, he said — when facing new germs, you want just enough of an immune response to subdue the threat without hurting the body itself.
"As humans transitioned from hunger-gatherers to living closely together in agricultural societies," Cobuccio said, "the pressure from infectious diseases increased, and a more balanced immune system may have been advantageous." Of course, this is a hypothesis; the exact pressures that lead to the variant's increase aren't known for sure.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
an hour ago
- Newsweek
Can Tackling Addictions Reduce Medicaid Costs?
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Discussions around Medicaid costs have become more heated than ever in recent months as President Donald Trump's administration tries to push its budget bill through the legislative ranks. House Republicans have instructed the House Committee on Energy and Commerce to slash $880 billion in spending over the next decade, with Medicaid making up 93 percent of the committee's budget. As a result, the amount of money the federal Medicaid program needs to provide health care services for more than 70 million Americans has been under dispute, with some arguing there is significant waste and misuse of money in the system, while others have warned cuts would leave millions of vulnerable people without access to health care. While lawmakers continue debating the divisive legislation, experts have discussed with Newsweek whether there could be another way of reducing Medicaid costs—tackling substance use disorders. Medicaid enrollees with substance use disorders require significantly higher health costs than those without—around $1,200 per month on average compared to $550, according to KFF. Around 7.2 percent of Medicaid recipients age 12 to 64 have a diagnosed substance use disorder, and treatment is key to addressing overdoses, deaths and other health or social complications, KFF reported. So could tackling substance use disorders in turn reduce costs for the Medicaid program? Here's what experts told Newsweek. Photo-illustration by Newsweek/Getty/Canva Why Are Medicaid Costs Higher for Those With Substance Use Disorders? The reason Medicaid enrollees with substance use disorders have higher health costs is because they often also have additional health complications, Dr. Joshua Lynch, professor of emergency and addiction medicine at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences, New York, told Newsweek. This could be physical health conditions, such as hypertension, high cholesterol and diabetes, or mental health disorders, "which can lead to more complex health care needs," he added. Those with substance use disorders also may "experience more fragmented care and more challenging access to high quality, lower cost care and preventative services," Lynch said. They may also struggle to work, or stay in work, and this may "contribute to increased reliance on higher-cost healthcare services," he added. Many Americans with substance use disorders also go undiagnosed, Brendan Saloner, professor of health policy and management at the John Hopkins Bloomberg School of Public Health, Maryland, told Newsweek. He added that those with substance addiction can have a lot of problems, such as the risk of overdose, or contracting blood-borne diseases like HIV or hepatitis C, as well as other issues, so "it's much better to get people into care proactively then to wait for their problems to become a crisis." The higher costs for those with substance use disorders, therefore, could "reflect the devastating physical consequences of substance use itself," Heidi Allen, professor of social work at the Columbia University School of Social Work, New York, told Newsweek, pointing to overdoses, increased vulnerability for chronic illness and exposure to infectious diseases. It's also not just about health complications, John Kelly, professor of psychiatry at Harvard Medical School and director of the Recovery Research Institute at Massachusetts General Hospital, told Newsweek. "The nature of these disorders means also that, on average, in the Medicaid population, individuals suffering from substance use disorder tend to have more social instability in terms of secure housing, employment, and criminal justice complications. These all contribute to increased costs," he said. Could Tackling Substance Use Disorders Reduce Medicaid Costs? While tackling substance use disorders may not slash Medicaid costs in the short term, as it would require investment in prevention and treatment, it could have positive economic impacts in the long run. "Prioritizing substance use treatment for enrollees might not reduce Medicaid costs in the short term, since we would expect more Medicaid enrollees to engage with treatment, which itself costs money," Allen said. However, she added that "it could certainly improve the health of enrollees, which might result in Medicaid savings down the road." If patients also have access to high-quality treatment and are able to manage their condition, "they have a lower reliance on high-cost health care such as emergency visits and inpatient hospitalizations," Lynch said. He added that other comorbidities also become more manageable, while housing stability and employment turn more achievable. "All of these will lead to a decrease in overall Medicaid spending," he said. Kelly also said he thought that tackling substance use disorders could reduce costs for Medicaid, adding that "focus on earlier intervention, and better implementation of care coordination will result in reduced use of more expensive acute medical care services, as well as prevention of the contraction of more chronic disease such as alcohol-associated liver diseases, HIV and hepatitis infections." "I am very confident that it would help to prevent some long-term costs to the program and would have a huge impact on other non-health needs like employment and reduced incarceration," Saloner said. But he added that whether it fully pays for itself, or saves money, is a more difficult question to answer. "We have some older studies showing that substance use care can offset lots of costs to society, but purely from the perspective of the Medicaid budget it's hard to say. The quality of life gains make it very cost-effective, whether or not it's cost saving," he said. Carrie Fry, professor in the department of health policy at Vanderbilt University School of Medicine, Tennessee, told Newsweek: "Research shows that addressing substance use disorder with effective, evidence-based treatments reduces Medicaid costs." In order to cut Medicaid costs, Fry said, making it easier for people with substance use disorders "to start and remain on effective treatment" would be an important step in the process. "For opioid use disorder, this means expanding availability of medications for opioid use disorder including methadone, buprenorphine, and naltrexone," she said. She added that only about half of Medicaid enrollees with an opioid use disorder receive evidence-based treatment in a given year. "So, treatment is an important first step to addressing the burden of substance use disorders in Medicaid and can reduce or prevent additional downstream costs," Fry said. She added that reducing the prevalence of substance use disorder via prevention will "require a more comprehensive approach to addressing broader social conditions that lead to increased risk of developing a substance use disorder."
Yahoo
10 hours ago
- Yahoo
Trillium Health to celebrate annual White Party fundraiser
ROCHESTER, N.Y. (WROC) — Trillium Health will host an evening of entertainment and advocacy for its largest annual fundraising event on Saturday. The White Party is held to advance Trillium Health's effort to end the HIV epidemic and provide individuals with accessible healthcare and resources. Trillium Health is a Federally Qualified Health Center that takes a holistic approach to providing comprehensive care to over 20,000 patients throughout the Greater Rochester area. Formerly known as the Community Health Network before expanding to Trillium Health in 2016, the organization was founded by Dr. William Valenti and Dr. Steven Scheibel as an HIV and AIDS clinic in 1989. They also serve the community with primary care and additional health services. Pittsford CommUNITY to host pride walk, celebration 'We are beyond excited to host The White Party once again and bring our community together for an unforgettable night. This event plays a critical role in supporting our work, ensuring we can continue providing accessible care to all, no matter their financial situation,' President and CEO of Trillium Health, Jason Barnecut-Kearns, said. The ticketed event will include an open bar, gourmet tasting stations, and dancing for attendees from 7 p.m. until 11 p.m. at the Mercantile on Main. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
12 hours ago
- Yahoo
FAA requires SpaceX to investigate Starship Flight 9 mishap
When you buy through links on our articles, Future and its syndication partners may earn a commission. SpaceX needs to figure out what happened on the ninth test flight of its Starship megarocket, the U.S. Federal Aviation Administration (FAA) has decreed. Flight 9, which lifted off from SpaceX's Starbase site in South Texas on Tuesday (May 27), ended in the destruction of both of Starship's stages — its Super Heavy booster and Ship upper stage (which is also sometimes known, somewhat confusingly, as Starship). But the FAA, which grants launch licenses for U.S. operators, is only concerned about one of those explosive events. "The mishap investigation is focused only on the loss of the Starship vehicle, which did not complete its launch or reentry as planned," FAA officials wrote in an update today (May 30). "The FAA determined that the loss of the Super Heavy booster is covered by one of the approved test induced damage exceptions requested by SpaceX for certain flight events and system components," the agency explained. "The FAA evaluated each exception prior to launch approval and verified they met public safety requirements." SpaceX broke new ground on Flight 9, reusing a Super Heavy for the first time ever. This particular booster first flew on Flight 7 in January, acing its engine burn and then returning to Starbase for a successful and dramatic catch by the launch tower's "chopstick" arms. The company did not attempt another catch on Flight 9. It conducted a variety of experiments with the booster, including bringing it down to Earth on a higher "angle of attack" to increase atmospheric drag. So, for safety's sake, SpaceX steered Super Heavy toward a "hard splashdown" in the Gulf of Mexico on Tuesday. This didn't quite work out, however. "Contact with the booster was lost shortly after the start of landing burn when it experienced a rapid unscheduled disassembly approximately 6 minutes after launch, bringing an end to the first reflight of a Super Heavy booster," SpaceX wrote in a Flight 9 recap. Ship had an even harder time on Flight 9. The upper stage was supposed to make a soft splashdown in the Indian Ocean off the coast of Western Australia about 65 minutes after launch, but it suffered an "attitude control error" that prevented the vehicle from getting into the proper orientation for reentry. "Starship then went through an automated safing process to vent the remaining pressure to place the vehicle in the safest condition for reentry," SpaceX wrote in the recap. "Contact with Starship was lost approximately 46 minutes into the flight, with all debris expected to fall within the planned hazard area in the Indian Ocean." Related stories: — SpaceX reached space with Starship Flight 9 launch, then lost control of its giant spaceship (video) — Starship and Super Heavy explained — SpaceX loses Starship rocket stage again, but catches giant Super Heavy booster during Flight 8 launch (video) This was still a considerable improvement over Ship's performance on its previous two liftoffs. On both Flight 7 and Flight 8 (which launched in March), Ship was lost less than 10 minutes after liftoff, raining debris down over the Atlantic. There have been no reports of injuries or damage to public property as a result of the Flight 9 mishap, according to the FAA. There were also minimal effects on flights in U.S. airspace — an improvement over the previous two Starship launches. "The FAA activated a Debris Response Area, out of an abundance of caution, when the Super Heavy booster experienced its anomaly over the Gulf of America during its flyback toward Texas," FAA officials wrote. "The FAA subsequently determined the debris did not fall outside of the hazard area," they added. "During the event, there were zero departure delays, one flight was diverted, and one airborne flight was held for 24 minutes."
